Synapse - Isabelle Riviere

Search Within

Isabelle C Riviere

Results (42)

Export to EndNote / Excel | PubMed

Evaluation of anti-tumor effects mediated by engineered T lymphocytes expressing a CD19 specific CAR for B cell lymphoma

Meeting Abstract

Tsukahara, T.; Ohmine, K.; Uchibori, R.; Ido, H.; Urabe, M.; Mizukami, H.; Kume, A.; Nakamura, M.; Riviere, I.; Sadelain, M.; more...
Molecular Therapy (2012)

Fulltext@MSK | Save

Targeting castration resistant prostate cancer (CRPC) with autologous PSMA-directed chimeric antigen receptor T cells

Meeting Abstract

Slovin, S. F.; Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Olszewska, M.; Taylor, C.; Wasielewska, T.; Bartido, S.; Poon, S.; Scher, H. I.; more...
Molecular Therapy (2012)

Fulltext@MSK | Save

Targeting intracellular antigens using chimeric antigen receptors

Meeting Abstract

Maus, M. V.; Merghoub, T.; Jakka, G.; Plotkin, J.; Stewart-Jones, G.; Riviere, I.; Wolchok, J.; Renner, C.; Sadelain, M.
Molecular Therapy (2012)

Fulltext@MSK | Save

Attenuated CTLA-4 inhibition in CD19-targeted T cells expressing a second-generation CD28-based chimeric antigen receptor

Meeting Abstract

Condomines, M.; Arnasson, J.; Benjamin, R.; Plotkin, J.; Gunset, G.; Riviere, I.; Sadelain, M.
Molecular Therapy (2012)

Fulltext@MSK | Save

Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI 3 kinase/AKT/Bcl-X L activation and CD8 T cell-mediated tumor eradication

Journal Article

Zhong, X. S.; Matsushita, M.; Plotkin, J.; Riviere, I.; Sadelain, M.
Molecular Therapy (2010)

Fulltext@MSK | Save

Treatment of chronic lymphocytic leukemia with genetically targeted autologous t cells: Case report of an unforeseen adverse event in a phase i clinical trial

Journal Article

Brentjens, R.; Yeh, R.; Bernal, Y.; Riviere, I.; Sadelain, M.
Molecular Therapy (2010)

Fulltext@MSK | Save

Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma

Journal Article

Wolchok, J. D.; Yuan, J.; Houghton, A. N.; Gallardo, H. F.; Rasalan, T. S.; Wang, J.; Zhang, Y.; Ranganathan, R.; Chapman, P. B.; Krown, S. E.; more...
Molecular Therapy (2007)

Fulltext@MSK | Save

Langerhans cells modified by gene transfer of full length CMV pp65 are more potent inducers of cytolytic T lymphocytes in a CD4-dependent manner than either CMV p495 gene-modified or p495 peptide-pulsed Langerhans cells

Meeting Abstract

Yuan, J.; Latouche, J. B.; Hodges, J.; Heller, G.; Riviere, I.; Sadelain, M.; Young, J. W.
Molecular Therapy (2004)

Fulltext@MSK | Save

Validation of viable producer cell removal/inactivation from clinical-grade oncoretroviral vector supernatant produced in cell factories

Meeting Abstract

Przybylowski, M.; Hakakha, A.; Fan, Y.; Riviere, I.
Molecular Therapy (2004)

Fulltext@MSK | Save

Position and copy number dependence of the central polypurine tract (cPPT) function in simple and complex lentiviral vectors

Meeting Abstract

Chang, A. H.; Lisowski, L.; Stephan, M.; Riviere, I.; Sadelain, M.
Molecular Therapy (2004)

Fulltext@MSK | Save